Oral testosterone must be methylated as part of hormone therapy for women with reduced sexual desire, and may have negative metabolic effects compared with transdermal bioidentical testosterone.
Panelists discuss how to effectively integrate vasomotor symptom (VMS) treatment into comprehensive health management plans for women, taking into account the significant comorbidities associated with ...
Treatments for estrogen-dependent cancers often focus on reducing estrogen levels or blocking estrogen receptors to slow cancer progression, using therapies such as hormone-blocking medications.